Journal
TRENDS IN MOLECULAR MEDICINE
Volume 17, Issue 9, Pages 506-517Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2011.05.004
Keywords
-
Funding
- NHLBI NIH HHS [R01 HL045565] Funding Source: Medline
- NIAMS NIH HHS [R01 AR060733, R01 AR045653] Funding Source: Medline
Ask authors/readers for more resources
DNA repeat expansions can result in the production of toxic RNA. RNA toxicity has been best characterised in the context of myotonic dystrophy. Nearly 20 mouse models have contributed significant and complementary insights into specific aspects of this novel disease mechanism. These models provide a unique resource to test pharmacological, anti-sense, and gene-therapy therapeutic strategies that target specific events of the pathobiological cascade. Further proof-of-principle concept studies and preclinical experiments require critical and thorough analysis of the multiple myotonic dystrophy transgenic lines available. This review provides in-depth assessment of the molecular and phenotypic features of these models and their contribution towards the dissection of disease mechanisms, and compares them with the human condition. More importantly, it provides critical assessment of their suitability and limitations for preclinical testing of emerging therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available